An outstanding experience for every patient
Go to home page
For patients and visitors
About Us
Why choose us?
Keeping healthy

New Research Grant for Salisbury Scientists 

Scientists at the Wessex Regional Genetics Laboratory at Salisbury District Hospital have been awarded a further £923,000 grant from Leukemia & Lymphoma Research to continue their groundbreaking research into a group of blood disorders that affects more than 25,000 people in the UK.

The disorders, known as myeloproliferative neoplasms, involve the excess production of blood cells that in some cases may progress to full-blown leukaemia. The grant follows a recent breakthrough by the team, which works in conjunction with the University of Southampton, who found a striking genetic susceptibility to the development of mutations in these disorders.

This breakthrough represented an important step forward in the understanding of the causes of these disorders and also provided a more general insight into why some people might be predisposed to acquiring genetic mutations that lead to cancers.

Professor Nick Cross, Director of the Wessex Regional Genetics Laboratory at Salisbury District Hospital said: "The grant is for a three year programme of research and will enable us to carry on with our important work. We will use state of the art techniques to identify and assess the significance of the genetic changes that cause the cancer to progress and we anticipate that this work will help in the development of treatment and therapies."

Notes to Editors

1. Leukaemia & Lymphoma Research is the only UK charity solely dedicated to research into blood cancers, including leukaemia, lymphoma and myeloma. These cancers are diagnosed in around 28,500 children, teenagers and adults in the UK every year. Leukaemia & Lymphoma Research was previously known as Leukaemia Research and has changed its name to raise awareness of its longstanding commitment to research into all the blood cancers - not just leukaemia.

2. Leukaemia & Lymphoma Research celebrates its 50th anniversary in 2010 and its expertise and focus enables them to invest in only the best UK research into better diagnosis, treatments and cures. As it receives no government funding and relies entirely on voluntary support, it needs to raise £120 million in the next five years to continue this life-saving research. Further information, including patient information booklets, is available from or on 020 7405 0101.



For further information please contact:
Patrick Butler
Public Relations Manager
Salisbury NHS Foundation Trust.
Tel: 01722 42517

For further information about Leukaemia & Lymphoma Research please contact:


Henry Winter
Press Officer
Leukaemia & Lymphoma Research
Tel: 020 7269 9019
Email :




Page Last Updated: 08/05/2014 10:06 
Printed from Salisbury NHS Foundation Website